NEU 2.37% $19.39 neuren pharmaceuticals limited

They could share the data however that party would then be an...

  1. 750 Posts.
    lightbulb Created with Sketch. 88
    They could share the data however that party would then be an insider and couldn’t make a bid until all of the information was publicly available.
    I can’t see any reason at all why Jon would share any information about the progress of the 3 P2 trials with a third party in preference to all shareholders and other interested parties getting the information at the same time.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.